Predominance of HLA-Restricted Cytotoxic T-Lymphocyte Responses to Serotype-Cross-Reactive Epitopes on Nonstructural Proteins following Natural Secondary Dengue Virus Infection
暂无分享,去创建一个
D. Vaughn | S. Kalayanarooj | S. Green | A. Rothman | F. Ennis | I. Kurane | D. Chandanayingyong | S. Suntayakorn | H. Stephens | A. Mathew | S. Green
[1] A. Nisalak,et al. Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.
[2] M. Sirikong,et al. HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais. , 1997, Human immunology.
[3] A. Rothman,et al. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. , 1996, The Journal of clinical investigation.
[4] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[5] F. Ennis,et al. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones , 1996, Journal of virology.
[6] F. Ennis,et al. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones , 1996, Journal of virology.
[7] F. Ennis,et al. Establishment of dengue virus-specific human CD4+ T lymphocyte clones from Percoll-purified T lymphoblasts by stimulation with monoclonal antibody to CD3. , 1995, Journal of immunological methods.
[8] F. Ennis,et al. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. , 1995, Journal of immunology.
[9] P. Parham,et al. The essence of epitopes , 1994, The Journal of experimental medicine.
[10] A. Müllbacher,et al. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. , 1994, Virology.
[11] D. Vaughn,et al. Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination , 1993, Journal of virology.
[12] F. Ennis,et al. Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone , 1993, Journal of virology.
[13] I. Kurane,et al. Immunity and immunopathology in dengue virus infections. , 1992, Seminars in immunology.
[14] A. Nisalak,et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.
[15] F. Ennis,et al. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones , 1991, Journal of virology.
[16] R. Chanock,et al. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a , 1989, Journal of virology.
[17] R. Chanock,et al. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus , 1987, Journal of virology.
[18] S. Halstead,et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.
[19] F. Ennis,et al. Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity , 1984, Journal of virology.
[20] R. M. Scott,et al. Histocompatibility antigens and dengue hemorrhagic fever. , 1981, American Journal of Tropical Medicine and Hygiene.
[21] S. Cohen,et al. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. , 1970, The Yale journal of biology and medicine.
[22] S. Halstead. 5 – Immunological Parameters of Togavirus Disease Syndromes , 1980 .
[23] I. Kurane,et al. Cytotoxic T Lymphocytes , 2022 .